secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0000320017-24-000034
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lisata shareholders approve all six proposals at 2024 annual meeting
--------------------------------------------------------------------

- Re-elected Class II directors Brown, Henson, and Mazzo; votes ranged from 3.15M to 3.26M for.
- Approved 2018 Equity Plan amendment adding 600k shares and a 3-year evergreen clause (5% or board-set).
- Approved ESPP increase from 68,333 to 113,333 shares; 3.06M for, 131k against.
- Ratified Grant Thornton as auditor for FY2024; 3.71M for, 401k against, no broker non-votes.
- Non-binding advisory vote on executive compensation passed with 3.09M for, 417k against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000032001724000034/0000320017-24-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000032001724000034/clbs-20240627.htm
  HTML page:      https://secwatch.observer/filing/0000320017-24-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer